Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
DeFilipp Z, Troschel FM, Qualls DA, Li S, Kuklinski MW, Kempner ME, Hochberg E, Chen YB, El-Jawahri A, Fintelmann FJ. DeFilipp Z, et al. Among authors: qualls da. Biol Blood Marrow Transplant. 2018 Aug;24(8):1741-1747. doi: 10.1016/j.bbmt.2018.02.016. Epub 2018 Mar 1. Biol Blood Marrow Transplant. 2018. PMID: 29496561 Free article.
High-dose Thiotepa, Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation as Upfront Consolidation for Systemic Non-Hodgkin Lymphoma With Synchronous Central Nervous System Involvement.
Qualls D, Sullivan A, Li S, Brunner AM, Collier K, Hochberg E, Armand P, Batchelor TT, Chen YB, DeFilipp Z. Qualls D, et al. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):884-888. doi: 10.1016/j.clml.2017.08.100. Epub 2017 Aug 15. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28870642
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Qualls DA, Lambert N, Caimi PF, Merrill M, Pullarkat P, Godby RC, Bond DA, Wehmeyer GT, Romancik J, Amoozgar B, Leslie L, Nastoupil LJ, Crombie JL, Abramson JS, Khurana A, Nowakowski GS, Maddocks K, Rutherford SC, Kahl B, Okwali M, Buege MJ, Seshan V, Batlevi CL, Salles G. Qualls DA, et al. Blood. 2023 Dec 28;142(26):2327-2331. doi: 10.1182/blood.2023021274. Blood. 2023. PMID: 37738563
A road map for navigating CAR T hematotoxicity.
Qualls D, Jacobson C. Qualls D, et al. Blood. 2023 Sep 7;142(10):859-861. doi: 10.1182/blood.2023021305. Blood. 2023. PMID: 37676695 No abstract available.
A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma.
Qualls D, Lam HY, Whiting K, Kumar A, Matasar M, Owens C, Nichols C, Espeleta JA, Qiu A, Subzwari S, Biggar E, Seshan V, Salles G, Younes A, Batlevi C. Qualls D, et al. Blood Adv. 2022 Sep 27;6(18):5262-5266. doi: 10.1182/bloodadvances.2021006555. Blood Adv. 2022. PMID: 35171976 Free PMC article. Clinical Trial. No abstract available.
Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
Qualls D, Jacobson CA. Qualls D, et al. Blood Adv. 2023 Jul 25;7(14):3469-3471. doi: 10.1182/bloodadvances.2023009834. Blood Adv. 2023. PMID: 37450319 Free PMC article. No abstract available.
22 results